Articles related to WOMEN'S HEALTH

Female mice recovering from a single ketamine exposure demonstrated microglia-driven neuroplasticity through FKBP51 activation, while male mice did not. The findings identify a sex-specific biologic pathway in a preclinical model, and human relevance remains unconfirmed.

Women presenting with acute myocardial infarction often report chest pain alongside additional symptoms such as dyspnea, nausea, fatigue, or jaw pain. Persistent diagnostic disparities continue to contribute to delays in recognition and treatment, particularly among younger women.

ASCO released updated recommendations for recurrent ovarian cancer that reinforce platinum-based doublet therapy as the preferred approach for platinum-sensitive disease and provide guidance for platinum-resistant disease, maintenance strategies, and monitoring. Recommendations were derived from a systematic review of studies published through 2025.

A Phase 2 trial of luvesilocin reported rapid reductions in postpartum depression symptoms, with most treated participants reaching remission within seven days. The investigational psychedelic has received FDA Breakthrough Therapy designation, but Phase 3 confirmation remains pending.

A federal court allowed a lawsuit against a hospital to proceed after a patient’s placenta was destroyed despite a signed release form. The ruling focused on contractual obligations and patient-directed handling of biological specimens.

Among more than 117,000 women followed in two Nurses’ Health Study cohorts, greater resistance-training participation was associated with lower rates of major cardiovascular disease. Risk reductions were most pronounced when strength training was paired with aerobic exercise.